[EN] INDAZOLE AND AZAINDAZOLE BTK INHIBITORS<br/>[FR] INHIBITEURS DE LA BTK DE TYPE INDAZOLE ET AZAINDAZOLE
                        
                            
                                申请人:MERCK SHARP & DOHME
                            
                            
                                公开号:WO2016161571A1
                            
                            
                                公开(公告)日:2016-10-13
                            
                            The present invention provides Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula (I), or pharmaceutically acceptable salts thereof, wherein X1, X2, R1, R7, R8 and R9 are as herein described. The present invention also provides pharmaceutical compositions comprising these compounds and methods for their use in therapy. In particular, the present invention relates to the use of Btk inhibitor compounds of Formula (I) in the treatment of Btk mediated disorders.